Magdi Moussa

Publications by Year

Research Areas

Liver physiology and pathology, PI3K/AKT/mTOR signaling in cancer, Pancreatic and Hepatic Oncology Research, Cancer Mechanisms and Therapy, Organometallic Complex Synthesis and Catalysis

Most-Cited Works

• → ARQ 197, a Novel and Selective Inhibitor of the Human c-Met Receptor Tyrosine Kinase with Antitumor Activity(2010)319 cited
• → Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor(2016)105 cited
• → Discovery and Optimization of a Series of 3-(3-Phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amines: Orally Bioavailable, Selective, and Potent ATP-Independent Akt Inhibitors(2012)99 cited
• ARQ 197, a highly selective small molecule inhibitor of c-Met, with selective antitumor properties in a broad spectrum of human cancer cells(2007)
• → Total synthesis of the cyclodepsipeptide ionophore pithomycolide(1996)4 cited
• → Structural and synthetic studies of pithomycolide(1994)3 cited
• → Supplementary Data from ARQ 197, a Novel and Selective Inhibitor of the Human c-Met Receptor Tyrosine Kinase with Antitumor Activity(2023)
• → Abstract 3905: Synthesis and structure activity relationship of substituted N,6-diphenyl-5,6-dihydrobenzo[h]quinazolin-2-amine as inhibitors of fibroblast growth factor receptors (FGFR)(2012)
• → Data from ARQ 197, a Novel and Selective Inhibitor of the Human c-Met Receptor Tyrosine Kinase with Antitumor Activity(2023)